title: Clinical characteristics of rapidly progressive leuko-araiosis.
abstract: BACKGROUND
  38 patients found to have either pure leuko-araiosis (LA) or LA combined with infarction(s) on computer tomography (CT) in 1989 were re-examined in 1992 in order to evaluate the progression of LA. The follow-up period averaged 3.2 years.
  
  
  METHODS
  The clinical and radiological data on patients in 1989 were collected from hospital records and re-evaluated. The patients were re-examined clinically (including 24 hour ambulatory blood pressure measurement), and neuroradiologically (CT) in 1992 for this study.
  
  
  RESULTS
  11 (29%) patients were found to have significant (rapid) progression of the extent of LA on CT during the follow-up. At baseline, there was no significant difference in the mean number of brain infarctions between the groups with progressing (prLA) and non-progressing LA (nprLA) or between the number of cortical and central infarctions within these groups. At follow-up, the total number of infarctions had increased significantly in both groups, but it was mostly because of the increase in cortical infarctions in the prLA group (p = 0.043) and, conversely, the central ones in the nprLA group (p = 0.011). prLA was found to be related to heart failure (82% vs 37%, p = 0.029) and atrial fibrillation (55% vs 19%, p = 0.047), whereas nprLA was strongly associated with a sudden onset of symptoms (78% vs prLA 18%, p = 0.001) like a true brain infarction. Other clinical factors, including mean blood pressure and heart rate, did not clearly differentiate between the groups.
  
  
  CONCLUSIONS
  The results suggest that there are different subgroups of patients with LA associated with various vascular factors. The occurrence of LA is not related to the distribution of infarctions. The progression of LA is not related to the number of brain infarctions or to the simultaneous increase of infarctions on CT.
authors.affiliation: Department of Geriatric Medicine, University of Turku, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Tarvonen-Schröder
authors.forename: I
authors.initials: I
authors.lastname: Räihä
authors.forename: T
authors.initials: T
authors.lastname: Kurki
authors.forename: T
authors.initials: T
authors.lastname: Rajala
authors.forename: L
authors.initials: L
authors.lastname: Sourander
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy; D015924:Blood Pressure Monitors; D001921:Brain / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology; D002544:Cerebral Infarction / Q000175:diagnosis*; D002552:Cerebral Ventricles / Q000473:pathology*; D003704:Dementia / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006429:Hemiplegia / Q000175:diagnosis; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D009460:Neurologic Examination; D010348:Patient Care Team; D014057:Tomography, X-Ray Computed